Myelodysplastic syndromes (MDS) describe cancers resulting from abnormal cells in the bone marrow. The abnormal bone marrow cells generate defective blood cells, which die earlier than normal blood ...

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ -- Quest Diagnostics (DGX), a ...

The UAB Flow Cytometry Lab is home to a staff of medical laboratory professionals who perform complex testing using state-of-the-art flow cytometry equipment. This testing, through research, education ...

The last decade has seen a revolution in cancer immunotherapy. The demand from doctors, researchers, and pharmaceutical companies for more precise results with high sensitivity and high-quality ...

Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...

Barrett’s esophagus (BE) is a precursor of esophageal adenocarcinoma (EAC). Both low-grade dysplasia (LGD) and high-grade dysplasia (HGD) are associated with an increased risk of progression to EAC.

Stopping multiple myeloma treatment too soon could increase symptoms and shorten your life. Myeloma can “hide” as minimal residual disease (MRD), even when you feel well. Flow cytometry testing about ...

Teaching of flow cytometry, histocompatibility, and immunology are combined into a one month rotation with the resident spending two weeks in flow cytometry, one week in the histocompatibility ...

"Our Flow Cytometry MRD for Myeloma test harnesses cutting-edge science and technology to deliver ultrasensitive insights from a noninvasive blood test, thereby improving care and value for patients ...